Cargando…
Shikonin and 4-hydroxytamoxifen synergistically inhibit the proliferation of breast cancer cells through activating apoptosis signaling pathway in vitro and in vivo
BACKGROUND: Tamoxifen (TAM) is a cell type-specific anti-estrogen and is applied to improve the survival of patients with estrogen receptor positive (ER +) breast cancer. However, long-term TAM use can induce serious drug resistance, leading to breast cancer recurrence and death in patients. Further...
Autores principales: | Lin, Hong-Yan, Han, Hong-Wei, Wang, Yin-Song, He, De-Liu, Sun, Wen-Xue, Feng, Lu, Wen, Zhong-Ling, Yang, Min-Kai, Lu, Gui-Hua, Wang, Xiao-Ming, Qi, Jin-Liang, Yang, Yong-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063777/ https://www.ncbi.nlm.nih.gov/pubmed/32175001 http://dx.doi.org/10.1186/s13020-020-00305-1 |
Ejemplares similares
-
Preparation, cellular uptake and angiogenic suppression of shikonin-containing liposomes in vitro and in vivo
por: Xia, Hongmei, et al.
Publicado: (2013) -
On the Mechanism of Membrane Permeabilization by Tamoxifen and 4-Hydroxytamoxifen
por: Ortiz, Julia, et al.
Publicado: (2023) -
Differential relieving effects of shikonin and its derivatives on inflammation and mucosal barrier damage caused by ulcerative colitis
por: Han, Hongwei, et al.
Publicado: (2021) -
Shikonin Inhibits Cholangiocarcinoma Cell Line QBC939 by Regulating Apoptosis, Proliferation, and Invasion
por: Liu, Chang, et al.
Publicado: (2021) -
Regulated control of virus replication by 4-hydroxytamoxifen-induced splicing
por: Zhao, Zhenghao, et al.
Publicado: (2023)